Acadia Pharmaceuticals May Subject Of A Bidding War

Acadia Pharmaceuticals

shares are trading higher by $2.94 at $39.01 in Monday's session. After the close on Friday, rumors surfaced that up to four companies may be potential bidders for the company. Those mentioned were AstraZeneca

, Teva Pharmaceuticals

, Bigoen

and Allergan

. The rumors instigated a higher and a brief retreat into the upper portion of Friday's range (Friday's high was $36.83), to $36.48, the rally continue din earnest. It has continued to make new highs for the day with the current one standing at $39.13. This marks the highest level for the issue since it peaked on November 30 at $39.41.